» Articles » PMID: 29330711

Boosting Tendon Repair: Interplay of Cells, Growth Factors and Scaffold-free and Gel-based Carriers

Overview
Journal J Exp Orthop
Publisher Wiley
Specialty Orthopedics
Date 2018 Jan 14
PMID 29330711
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tendons are dense connective tissues and critical components for the integrity and function of the musculoskeletal system. Tendons connect bone to muscle and transmit forces on which locomotion entirely depends. Due to trauma, overuse and age-related degeneration, many people suffer from acute or chronic tendon injuries. Owing to their hypovascularity and hypocellularity, tendinopathies remain a substantial challenge for both clinicians and researchers. Surgical treatment includes suture or transplantation of autograft, allograft or xenograft, and these serve as the most common technique for rescuing tendon injuries. However, the therapeutic efficacies are limited by drawbacks including inevitable donor site morbidity, poor graft integration, adhesion formations and high rates of recurrent tearing. This review summarizes the literature of the past 10 y concerning scaffold-free and gel-based approaches for treating tendon injuries, with emphasis on specific advantages of such modes of application, as well as the obtained results regarding in vitro and in vivo tenogenesis.

Results: The search was focused on publications released after 2006 and 83 articles have been analysed. The main results are summarizing and discussing the clear advantages of scaffold-free and hydrogels carriers that can be functionalized with cells alone or in combination with growth factors.

Conclusion: The improved understanding of tissue resident adult stem cells has made a significant progress in recent years as well as strategies to steer their fate toward tendon lineage, with the help of growth factors, have been identified. The field of tendon tissue engineering is exploring diverse models spanning from hard scaffolds to gel-based and scaffold-free approaches seeking easier cell delivery and integration in the site of injury. Still, the field needs to consider a multifactorial approach that is based on the combination and fine-tuning of chemical and biomechanical stimuli. Taken together, tendon tissue engineering has now excellent foundations and enters the period of precision and translation to models with clinical relevance on which better treatment options of tendon injuries can be shaped up.

Citing Articles

Use of a bioresorbable polylactide sheet (OrthoWrap Bioresorbable sheet) on tendon healing after extensor tendon repair: a controlled clinical trial.

Tafti A, Mohammadi H, Rezaei M, Bonadaki S BMC Musculoskelet Disord. 2025; 26(1):1.

PMID: 39743570 PMC: 11694381. DOI: 10.1186/s12891-024-08241-z.


Erroneous Differentiation of Tendon Stem/Progenitor Cells in the Pathogenesis of Tendinopathy: Current Evidence and Future Perspectives.

Gao Y, Wang H, Shi L, Lu P, Dai G, Zhang M Stem Cell Rev Rep. 2024; 21(2):423-453.

PMID: 39579294 DOI: 10.1007/s12015-024-10826-z.


FGF-2 enriched nanofiber scaffold for advancing achilles tendon healing: a comparative experimental investigation.

Turgut N, Cengiz Callioglu F, Bayraktar A, Savran M, Asci H, Gulle K Front Surg. 2024; 11:1424734.

PMID: 39483374 PMC: 11524941. DOI: 10.3389/fsurg.2024.1424734.


An Inquiry-Based Learning STEM Outreach Module to Teach Principles of Bioadhesives and Tissue Repair.

Panebianco M, Bhadouria N, Kim O, Frost J, Huang A, Dutta P Annu Conf Expo (Am Soc Eng Educ). 2024; 2023.

PMID: 39464699 PMC: 11512589. DOI: 10.18260/1-2--42628.


Mesenchymal Stromal Cells for the Enhancement of Surgical Flexor Tendon Repair in Animal Models: A Systematic Review and Meta-Analysis.

Epanomeritakis I, Eleftheriou A, Economou A, Lu V, Khan W Bioengineering (Basel). 2024; 11(7).

PMID: 39061739 PMC: 11274147. DOI: 10.3390/bioengineering11070656.


References
1.
Violini S, Ramelli P, Pisani L, Gorni C, Mariani P . Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol. 2009; 10:29. PMC: 2678092. DOI: 10.1186/1471-2121-10-29. View

2.
Docheva D, Muller S, Majewski M, Evans C . Biologics for tendon repair. Adv Drug Deliv Rev. 2014; 84:222-39. PMC: 4519231. DOI: 10.1016/j.addr.2014.11.015. View

3.
Yin Z, Chen X, Chen J, Shen W, Hieu Nguyen T, Gao L . The regulation of tendon stem cell differentiation by the alignment of nanofibers. Biomaterials. 2009; 31(8):2163-75. DOI: 10.1016/j.biomaterials.2009.11.083. View

4.
Abbah S, Spanoudes K, OBrien T, Pandit A, Zeugolis D . Assessment of stem cell carriers for tendon tissue engineering in pre-clinical models. Stem Cell Res Ther. 2014; 5(2):38. PMC: 4056691. DOI: 10.1186/scrt426. View

5.
James R, Kesturu G, Balian G, Chhabra A . Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options. J Hand Surg Am. 2008; 33(1):102-12. DOI: 10.1016/j.jhsa.2007.09.007. View